keyword
https://read.qxmd.com/read/38639912/re-attendance-in-supplemental-breast-mri-screening-rounds-of-the-dense-trial-for-women-with-extremely-dense-breasts
#21
JOURNAL ARTICLE
Stefanie G A Veenhuizen, Sophie E L van Grinsven, Isabelle L Laseur, Marije F Bakker, Evelyn M Monninkhof, Stéphanie V de Lange, Ruud M Pijnappel, Ritse M Mann, Marc B I Lobbes, Katya M Duvivier, Mathijn D F de Jong, Claudette E Loo, Nico Karssemeijer, Paul J van Diest, Wouter B Veldhuis, Carla H van Gils
OBJECTIVES: Supplemental MRI screening improves early breast cancer detection and reduces interval cancers in women with extremely dense breasts in a cost-effective way. Recently, the European Society of Breast Imaging recommended offering MRI screening to women with extremely dense breasts, but the debate on whether to implement it in breast cancer screening programs is ongoing. Insight into the participant experience and willingness to re-attend is important for this discussion. METHODS: We calculated the re-attendance rates of the second and third MRI screening rounds of the DENSE trial...
April 19, 2024: European Radiology
https://read.qxmd.com/read/38639279/cldn18-clinical-pathological-and-genetic-signatures-with-drug-screening-in-gastric-adenocarcinoma
#22
JOURNAL ARTICLE
Joon Young Hur, Kyueng-Whan Min, Yung-Kyun Noh, Young-Woong Won, Yoomi Yeo, Dong-Hoon Kim, Byoung Kwan Son, Mi Jung Kwon, Jung Soo Pyo
INTRODUCTION: The CLDN18 gene, encoding claudin 18.1 and claudin 18.2, is a key component of tight junction strands in epithelial cells that form a paracellular barrier that is critical in Stomach Adenocarcinoma (STAD). METHODS: Our study included 1,095 patients with proven STAD, 415 from The Cancer Genome Atlas (TCGA) cohort and 680 from the Gene Expression Omnibus database. We applied various analyses, including gene set enrichment analysis, pathway analysis, and in vitro drug screening to evaluate survival, immune cells, and genes and gene sets associated with cancer progression, based on CLDN18 expression levels...
April 18, 2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38638399/preventing-alpelisib-related-hyperglycaemia-in-hr-her2-pik3ca-mutated-advanced-breast-cancer-using-metformin-metallica-a-multicentre-open-label-single-arm-phase-2-trial
#23
JOURNAL ARTICLE
Antonio Llombart-Cussac, José Manuel Pérez-Garcia, Manuel Ruiz Borrego, Pablo Tolosa, Salvador Blanch, Adela Fernández-Ortega, Ander Urruticoechea, Isabel Blancas, Cristina Saura, Beatriz Rojas, Begoña Bermejo, José Ponce Lorenzo, María Gion, Patricia Cortez-Castedo, Elisenda Llabres, Elena Galve, Juan Fernando Cueva, Ana López, José Luis Alonso-Romero, Santiago González-Santiago, Eduardo Martínez de Dueñas, Eva Ciruelos, Griselda Martrat, Petra Gener, Daniel Alcalá-López, Miguel Sampayo-Cordero, Fernando Gómez-Peralta, Javier Cortés
BACKGROUND: Hyperglycaemia is an early and frequent adverse event during alpelisib treatment. METALLICA aimed to evaluate prophylactic metformin to prevent or reduce hyperglycaemia occurrence in patients with HR+/HER2-/ PIK3CA -mutated advanced breast cancer (ABC). METHODS: Between August 13th, 2020 and March 23rd, 2022, this 2-cohort, phase 2, multicentre, single-arm trial (NCT04300790) enrolled patients with HR+/HER2-/PIK3CA-mutated ABC: cohort A, normal glycaemia (fasting plasma glucose <100 mg/dL [<5...
May 2024: EClinicalMedicine
https://read.qxmd.com/read/38638044/il-7r-expression-correlates-with-prognosis-in-breast-cancer
#24
JOURNAL ARTICLE
Xiaojie Yu, Hao Zhang, Jing Liu, Changran Hou, Haojie Zhang, Zhenlin Yang
BACKGROUND: The tumor microenvironment (TME) exerts a significant influence on the development, invasion, metastasis, and drug resistance of breast cancer. Therefore, this study sought to investigate potential prognostic factors and markers indicative of TME remodeling in breast cancer, utilizing data from the TCGA database. METHODS: In this study, transcriptome RNA-seq data from 1222 breast cancer samples were processed using CIBERSORT and ESTIMATE algorithms. We conducted a differential gene expression analysis utilizing COX regression analysis and constructed protein-protein interaction (PPI) networks for enhanced visualization...
April 17, 2024: Combinatorial Chemistry & High Throughput Screening
https://read.qxmd.com/read/38637658/perception-predicts-patient-response-and-resistance-to-treatment-using-single-cell-transcriptomics-of-their-tumors
#25
JOURNAL ARTICLE
Sanju Sinha, Rahulsimham Vegesna, Sumit Mukherjee, Ashwin V Kammula, Saugato Rahman Dhruba, Wei Wu, D Lucas Kerr, Nishanth Ulhas Nair, Matthew G Jones, Nir Yosef, Oleg V Stroganov, Ivan Grishagin, Kenneth D Aldape, Collin M Blakely, Peng Jiang, Craig J Thomas, Cyril H Benes, Trever G Bivona, Alejandro A Schäffer, Eytan Ruppin
Tailoring optimal treatment for individual cancer patients remains a significant challenge. To address this issue, we developed PERCEPTION (PERsonalized Single-Cell Expression-Based Planning for Treatments In ONcology), a precision oncology computational pipeline. Our approach uses publicly available matched bulk and single-cell (sc) expression profiles from large-scale cell-line drug screens. These profiles help build treatment response models based on patients' sc-tumor transcriptomics. PERCEPTION demonstrates success in predicting responses to targeted therapies in cultured and patient-tumor-derived primary cells, as well as in two clinical trials for multiple myeloma and breast cancer...
April 18, 2024: Nature Cancer
https://read.qxmd.com/read/38637479/fragment-based-discovery-of-new-potential-dnmt1-inhibitors-integrating-multiple-pharmacophore-modeling-3d-qsar-virtual-screening-molecular-docking-adme-and-molecular-dynamics-simulation-approaches
#26
JOURNAL ARTICLE
Goverdhan Lanka, Suvankar Banerjee, Nilanjan Adhikari, Balaram Ghosh
DNA methyl transferases (DNMTs) are one of the crucial epigenetic modulators associated with a wide variety of cancer conditions. Among the DNMT isoforms, DNMT1 is correlated with bladder, pancreatic, and breast cancer, as well as acute myeloid leukemia and esophagus squamous cell carcinoma. Therefore, the inhibition of DNMT1 could be an attractive target for combating cancers and other metabolic disorders. The disadvantages of the existing nucleoside and non-nucleoside DNMT1 inhibitors are the main motive for the discovery of novel promising inhibitors...
April 18, 2024: Molecular Diversity
https://read.qxmd.com/read/38637147/advancing-breast-cancer-screening-a-call-for-updated-policy-and-practice
#27
JOURNAL ARTICLE
Iman Al Hashmi, Omar Al Omari
No abstract text is available yet for this article.
April 18, 2024: Evidence-based Nursing
https://read.qxmd.com/read/38636114/prediction-of-high-level-fear-of-cancer-recurrence-in-breast-cancer-survivors-an-integrative-approach-utilizing-random-forest-algorithm-and-visual-nomogram
#28
JOURNAL ARTICLE
Hui Ren, Tianye Yang, Xin Yin, Lingling Tong, Jianjun Shi, Jia Yang, Zhu Zhu, Hongyan Li
PURPOSE: This study is the first attempt to use a combination of regression analysis and random forest algorithm to predict the risk factors for high-level fear of cancer recurrence and develop a predictive nomogram to guide clinicians and nurses in identifying high-risk populations for high-level fear of cancer recurrence. METHODS: After receiving various recruitment strategies, a total of 781 survivors who had undergone breast cancer resection within 5 years in four Grade-A hospitals in China were included...
March 29, 2024: European Journal of Oncology Nursing: the Official Journal of European Oncology Nursing Society
https://read.qxmd.com/read/38635933/genomic-landscape-of-circulating-tumor-dna-in-patients-with-hormone-receptor-positive-human-epidermal-growth-factor-receptor-2-negative-metastatic-breast-cancer-treated-with-abemaciclib-data-from-the-scrum-japan-cancer-genome-screening-project
#29
JOURNAL ARTICLE
Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwata
PURPOSE: To understand the mutational landscape of circulating tumor DNA (ctDNA) and tumor tissue of patients with hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2-) metastatic breast cancer (MBC) treated with abemaciclib + endocrine therapy (ET). METHODS: Blood samples for ctDNA and/or tissue samples were collected from abemaciclib-treated patients with HR+/HER2- MBC enrolled in the SCRUM-Japan MONSTAR-SCREEN project. Blood samples were collected before abemaciclib initiation (baseline) and at disease progression/abemaciclib discontinuation (post abemaciclib treatment)...
April 2024: JCO Precision Oncology
https://read.qxmd.com/read/38635308/effectiveness-and-cost-effectiveness-of-survivorship-care-for-survivors-of-hodgkin-lymphoma-insight-study-protocol-for-a-multicenter-retrospective-cohort-study-with-a-quasi-experimental-design
#30
JOURNAL ARTICLE
Eline M J Lammers, Josée M Zijlstra, Valesca P Retèl, Berthe M P Aleman, Flora E van Leeuwen, Annelies Nijdam
BACKGROUND: Hodgkin lymphoma (HL) occurs at young ages, with the highest incidence between 20 and 40 years. While cure rates have improved to 80%-90% over the past decades, survivors of HL are at substantial risk of late treatment-related complications, such as cardiovascular diseases, breast cancer, severe infections, and hypothyroidism. To reduce morbidity and mortality from late treatment effects, the Dutch Better care after lymphoma, Evaluation of long-term Treatment Effects and screening Recommendations (BETER) consortium developed a survivorship care program for 5-year survivors of HL that includes risk-based screening for and treatment of (risk factors for) late adverse events...
April 18, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38635268/neighborhood-disadvantage-and-breast-cancer-specific-survival-in-the-us
#31
JOURNAL ARTICLE
Neha Goel, Alexandra E Hernandez, Angela Mazul
IMPORTANCE: Despite improvements in breast cancer screening, treatment, and survival, disparate breast cancer-specific survival outcomes persist, particularly in disadvantaged neighborhoods. Most of these disparities are attributed to disparities in individual, tumor, and treatment characteristics. However, a critical knowledge gap exists as to whether disparities in breast cancer-specific survival remain after accounting for individual, tumor, and treatment characteristics. OBJECTIVE: To evaluate if neighborhood disadvantage is associated with shorter breast cancer-specific survival after controlling for individual, tumor, and treatment characteristics in a national population...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38634039/identification-and-validation-of-novel-metastasis-related-immune-gene-signature-in-breast-cancer
#32
JOURNAL ARTICLE
Shen Ma, Ran Hao, Yi-Wei Lu, Hui-Po Wang, Jie Hu, Yi-Xin Qi
BACKGROUND: Distant metastasis remains the leading cause of death among patients with breast cancer (BRCA). The process of cancer metastasis involves multiple mechanisms, including compromised immune system. However, not all genes involved in immune function have been comprehensively identified. METHODS: Firstly 1623 BRCA samples, including transcriptome sequencing and clinical information, were acquired from Gene Expression Omnibus (GSE102818, GSE45255, GSE86166) and The Cancer Genome Atlas-BRCA (TCGA-BRCA) dataset...
2024: Breast Cancer: Targets and Therapy
https://read.qxmd.com/read/38633889/phytochemical-characterization-by-gc-ms-and-in-vitro-evaluation-of-antiproliferative-and-antimigratory-studies-of-leucas-aspera-leaf-extracts-on-mda-mb-231-cell-line
#33
JOURNAL ARTICLE
Mahaboob Begum S M Fazeela, Megasri Sankarram
Breast cancer is the most recurrently identified and one of women's prominent causes of death. Currently, researchers have turned their focus on natural chemicals from synthetic chemicals due to their environmental, economic, and health benefits. Considering this, the medicinal plant Leucas aspera was chosen for the current study. The aim of this study was to isolate and characterize secondary metabolites from L. aspera and determine the antiproliferative and antimigratory activities in the MDA-MB-231 cell line under in vitro conditions...
2024: Biotechnologia
https://read.qxmd.com/read/38633799/breast-imaging-with-an-ultra-low-field-mri-scanner-a-pilot-study
#34
Sheng Shen, Neha Koonjoo, Friderike K Longarino, Leslie R Lamb, Juan C Villa Camacho, Torben P P Hornung, Stephen E Ogier, Susu Yan, Thomas R Bortfeld, Mansi A Saksena, Kathryn E Keenan, Matthew S Rosen
Breast cancer screening is necessary to reduce mortality due to undetected breast cancer. Current methods have limitations, and as a result many women forego regular screening. Magnetic resonance imaging (MRI) can overcome most of these limitations, but access to conventional MRI is not widely available for routine annual screening. Here, we used an MRI scanner operating at ultra-low field (ULF) to image the left breasts of 11 women (mean age, 35 years ±13 years) in the prone position. Three breast radiologists reviewed the imaging and were able to discern the breast outline and distinguish fibroglandular tissue (FGT) from intramammary adipose tissue...
April 4, 2024: medRxiv
https://read.qxmd.com/read/38633004/the-effects-of-massage-therapy-in-decreasing-pain-and-anxiety-in-post-surgical-patients-with-breast-cancer-a-systematic-review-and-meta-analysis
#35
JOURNAL ARTICLE
Jill S Cole, Anne D Olson, Esther E Dupont-Versteegden
BACKGROUND: Massage therapy is an effective non-pharmacological intervention in treating pain and anxiety of patients with cancer. Prior studies have reviewed the benefits of massage therapy in patients with breast cancer undergoing chemotherapy, radiation, and other patient-specific cancer treatments. What has yet to be examined is the effects of massage therapy on the pain and anxiety of patients with breast cancer after surgery. OBJECTIVE: : The purpose of this systematic review and meta-analysis was to examine the effect of massage therapy on post-surgical pain and anxiety in patients with breast cancer...
2024: Glob Adv Integr Med Health
https://read.qxmd.com/read/38632642/spatial-and-single-cell-explorations-uncover-prognostic-significance-and-immunological-functions-of-mitochondrial-calcium-uniporter-in-breast-cancer
#36
JOURNAL ARTICLE
Chia-Jung Li, Yen-Dun Tony Tzeng, Jui-Hu Hsiao, Ling-Ming Tseng, Tzu-Sheng Hsu, Pei-Yi Chu
The mitochondrial calcium uniporter (MCU) is a transmembrane protein facilitating the entry of calcium ions into mitochondria from the cell cytosol. Maintaining calcium balance is crucial for enhancing cellular energy supply and regulating cell death. The interplay of calcium balance through MCU and the sodium-calcium exchanger is known, but its regulation in the breast cancer tumor microenvironment remains elusive. Further investigations are warranted to explore MCU's potential in BRCA clinical pathology, tumor immune microenvironment, and precision oncology...
April 17, 2024: Cancer Cell International
https://read.qxmd.com/read/38632333/a-multi-cancer-early-detection-blood-test-using-machine-learning-detects-early-stage-cancers-lacking-uspstf-recommended-screening
#37
JOURNAL ARTICLE
Janet Vittone, David Gill, Alex Goldsmith, Eric A Klein, Jordan J Karlitz
US Preventive Services Task Force (USPSTF) guidelines recommend single-cancer screening for select cancers (e.g., breast, cervical, colorectal, lung). Advances in genome sequencing and machine learning have facilitated the development of blood-based multi-cancer early detection (MCED) tests intended to complement single-cancer screening. MCED tests can interrogate circulating cell-free DNA to detect a shared cancer signal across multiple tumor types. We report real-world experience with an MCED test that detected cancer signals in three individuals subsequently diagnosed with cancers of the ovary, kidney, and head/neck that lack USPSTF-recommended screening...
April 17, 2024: NPJ Precision Oncology
https://read.qxmd.com/read/38632307/prevalence-of-breast-cancer-in-rural-population-of-jaipur-a-survey-based-observational-study
#38
JOURNAL ARTICLE
Roshni Singh, Sachin Kumar, Prashant Nakash, Ramesh Kumar, Govind Kumar, Pusparghya Pal, Shivang Mishra, Preeti Raj, Sumit Rajotiya, Anurag Kumar Singh, Sourav Debnath, Bhumi Chaturvedi, Hemant Bareth, Akhilesh Patel, Mahaveer Singh, Anurag Srivastava, Deepak Nathiya, Balvir Singh Tomar
Breast cancer, a global health concern predominantly affecting women, recorded 2.3 million new cases and 685,000 deaths in 2020. Alarmingly, projections suggest that by 2040, there could be over 3 million new cases and 1 million deaths. To assess breast cancer prevalence in 24 rural villages within a 60 km radius of NIMS Hospital, Tala Mod, Jaipur, Rajasthan, North India 303,121. A study involving 2023 participants conducted initial screenings, and positive cases underwent further tests, including ultrasound, mammography, and biopsy...
April 17, 2024: Scientific Reports
https://read.qxmd.com/read/38631535/a-two-center-study-of-a-combined-nomogram-based-on-mammography-and-mri-to-predict-aln-metastasis-in-breast-cancer
#39
JOURNAL ARTICLE
Yuchen Hua, Qiqi Peng, Junqi Han, Jie Fei, Aimin Sun
OBJECTIVES: To develop and validate a predictive method for axillary lymph node (ALN) metastasis of breast cancer by using radiomics based on mammography and MRI. MATERIALS AND METHODS: A retrospective analysis of 492 women from center 1 (The affiliated Hospital of Qingdao University) and center 2 (Yantai Yuhuangding Hospital) with primary breast cancer from August 2013 to May 2021 was carried out. The radscore was calculated using the features screened based on preoperative mammography and MRI from the training cohort of Center 1 (n = 231), then tested in the validation cohort (n = 99), an internal test cohort (n = 90) from Center 1, and an external test cohort (n = 72) from Center 2...
April 15, 2024: Magnetic Resonance Imaging
https://read.qxmd.com/read/38630597/assessing-the-value-of-incorporating-a-polygenic-risk-score-with-non-genetic-factors-for-predicting-breast-cancer-diagnosis-in-the-uk-biobank
#40
JOURNAL ARTICLE
Jennifer A Collister, Xiaonan Liu, Thomas J Littlejohns, Jack Cuzick, Lei Clifton, David J Hunter
BACKGROUND: Previous studies have demonstrated that incorporating a polygenic risk score (PRS) to existing risk prediction models for breast cancer improves model fit, but to determine its clinical utility the impact on risk categorisation needs to be established. We add a PRS to two well-established models and quantify the difference in classification using the net reclassification improvement (NRI). METHODS: We analysed data from 126,490 post-menopausal women of "White British" ancestry, aged 40-69 years at baseline from the UK Biobank prospective cohort...
April 17, 2024: Cancer Epidemiology, Biomarkers & Prevention
keyword
keyword
7240
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.